EPISODE · Jan 14, 2020 · 12 MIN
Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue
Embed this episode
Ready to play
Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more
0:00
12:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Editors' Summary?
This episode is 12 minutes long.
When was this JAMA Editors' Summary episode published?
This episode was published on January 14, 2020.
Can I download this JAMA Editors' Summary episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!